1. Abdel-Meguid, S. S., Shieh, H.-S., Smith, W. W., Dayringer, H. E., Violand, B. N., and Bentle, L. A., 1987, Three-dimensional structure of a genetically engineered variant of porcine growth hormone, Proc. Natl Acad. Sci. USA
84:6434–6437.
2. Azain, M. J., Kasser, T. R., Eigenberg, K. E., and Sabacky, M. J., 1988, Somatotropin prolonged release, European Patent Application, EP 0 283 458 A2.
3. Bogosian, G., Violand, B. N., Dorward-King, E. J., Workman, W. E., Jung, P. E., and Kane, J. F., 1989, Biosynthesis and incorporation into protein of norleucine by Escherichia coli, J. Biol. Chem. 264:531–539.
4. Bramley, M. R., Carter, A. B., and Dunwell, D. W., 1989, Somatotropin formulations, European Patent Application, EP 0 314 421 Al.
5. Brems, D. N., Plaisted, S. M., Havel, H. A., Kauffman, E. W., Stodola, J. D., Eaton, L. C., and White, R. D., 1985, Equilibrium denaturation of pituitary- and recom-binantly-derived bovine growth hormone, Biochemistry
24:7662–7668.